Huntington’s disease treated in UK trial, gene therapy slows progression by 75%
Source: news.sky.com Key Points: Gene therapy slows Huntington’s by 75%. Blocks toxic huntingtin protein. Breakthrough offers new hope. Huntington’s disease has been treated successfully for the first time in a gene therapy trial, researchers in the United Kingdom announced on Sept. 24. The therapy slowed the progression of the illness by 75% in patients three years after treatment, marking a breakthrough for a condition that has long been considered incurable. The trial was led by University College London’s Huntington’s disease center and directed by Prof. Sarah Tabrizi. The treatment targets the faulty gene responsible for the condition and is delivered through a one-time surgical procedure lasting 12 to 20 hours. How the therapy works The therapy uses a modified virus to deliver a strand of DNA into neurons. Once inside, the DNA prevents the production of a toxic protein called huntingtin, which causes the disease. The virus is infused through a microcatheter into two areas o...